Edwards Lifesciences Corporation provides sales guidance for the first quarter 2019. For the first quarter 2019, the company projects total sales to be between $950 million and $1.01 billion. The company expects sales in 2019 of $3.9 billion to $4.3 billion. Overall, 2019 sales guidance for the company remains unchanged.